Research Focus

Research and Technology Management; Program Manager, Study Start Up

Recent additions – View all

1. A phase I dose escalation trial of vaccine replicon particles (VRP) expressing prostate-specific membrane antigen (PSMA) in subjects with prostate cancer

   Journal Article

   Slovin, S. F.; Kehoe, M.; Durso, R.; Fernandez, C.; Olson, W.; Gao, J. P.; Israel, R.; Scher, H. I.; Morris, S.
   Vaccine (2013)

   Fulltext@MSK | Save
2. A phase I dose-escalation trial of vaccine replicon particles (VRP) expressing prostate-specific membrane antigen (PSMA) in patients (pts) with castration-resistant prostate cancer (CRPC): Final results

   Meeting Abstract

   Slovin, S. F.; Morris, S.; Kargman, M.; Durso, R.; Curley, T.; Israel, R. J.; Olson, W. C.; Murphy, D.; Scher, H. I.
   Journal of Clinical Oncology (2011)

   Fulltext@MSK | Save
3. A phase I dose escalation trial of vaccine replicon particles (VRP) expressing prostate-specific membrane antigen (PSMA) in patients (pts) with castration-resistant prostate cancer (CRPC): Preliminary results

   Meeting Abstract

   Slovin, S. F.; Kargman, M.; Durso, R.; Curley, T.; Israel, R. J.; Olson, W. C.; Morris, S.; Murphy, D.; Scher, H. I.
   Journal of Clinical Oncology (2011)

   Fulltext@MSK | Save